Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone for bipolar I depression
2008-007457-13Phase 3Completed
- Sponsor
- Sunovion
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lurasidone in bipolar I disorder and bipolar disorder (BD) (3 arms), sponsored by Sunovion. Primary endpoint: Change from baseline in MADRS total score. Started Jul 2009; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorderbipolar disorder (BD)
Beyond the preview
Go deeper on 2008-007457-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007457-13.